IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004
Serum IL-12p70 and IL-12p40 levels in severe asthma patients with fixed airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 234s Year: 2006
Polymorphisms of IL-4, IL-10, and TNF-α gene in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Evaluation in bronchoalveolar lavage fluid (BALF) of cytokines TNF-alpha, IL-6 and IL-8 in children with severe bronchial asthma (BA) Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
Release of IL-1b, IL-6 and TNF-a after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002
Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Inflammatory and regulatory cytokine IL-6 in plasma and BAL fluid of patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Serum levels of IL-10 and IL-12p40 in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 139s Year: 2007
Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Sputum CC-chemokines, IL-13 and pulmonary function in allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018
The concentration of IL-2, IL-4, IL-6 and IFNγ in nasal secretion in respiratory atopy and pseudoatopy Source: Eur Respir J 2005; 26: Suppl. 49, 485s Year: 2005
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001